Concepedia

Krystyna Jedynasty

KJ

Statistics

Publications

11

Citations

4.2K

H-Index

11

Active since

1996

Affiliations

Central Clinical Hospital(Current)

Medical University of Warsaw

Polish Academy of Sciences

Mossakowski Medical Research Institute, Polish Academy of Sciences

Eli Lilly (United States)

Krystyna Jedynasty is an author at Central Clinical Hospital specializing in medicine, diabetes mellitus, and diabetology.

Publications per year

1996–2023

11

Publications

11

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

, , +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

, , +15

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

, , +17

Independence of exogenous insulin following immunoablation and stem cell reconstitution in newly diagnosed diabetes type I

Emilian Snarski, Alicja Milczarczyk, T Torosian et al. · Bone Marrow Transplantation · 2010 · 96 citations

, , +14

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat et al. · Annals of Internal Medicine · 2023 · 88 citations

, , +17

1–5 of 11